Blood pressure regulators Flashcards
Hypotensive activity of drugs
decrease preload -> venodilation and reduced circulating blood flow volume
decrease afterload-> arteriodilation
decrease CO -> Negative inotropy, negative chronotropy
ACE-I
Inhibition of angiotensin converting enzyme
Vasodilation – hypotensive effect
↓ Heart preload and afterload, ↓ Cardiovascular remodelation, ↓Aldosterone secretion
Kaptopril short-acting
Enalapril/Enalaprilate(prodrug)
Perindopril
Arterial hypertension
Chronic heart failure
Coronary heart disease/ myocardial infarction
Diabetic nephropathy
SE: dry cough
(↑bradykinin),
hyperkalemia
(↓aldosterone)
Angiotensine receptor AT1 blockers
ARB
Blocks angiotensine II binding to
AT1 receptors
Venous and arterial vasodilation
(both ACE-I and ARB)
Does not affect bradykinin metabolism
Valsartan
Candesartan
Losartan
Arterial hypertension
Chronic heart failure
SE: Hyperkalemia
Calcium channel blockers
Arterial vasodilators
(↓ heart afterload)
inhibits Ca2 + entry into the heart and b /v muscle cells
In the smooth muscle Ca2+ and calmoduline complex does not form→ myosin light chain kinase is not activated →smooth muscle relaxes
Nifedipine
Amlodipine d.a. 24 h
Nicardipine
Arterial hypertension
Prophylaxis (stable exertion) of angina pectoris
Coronary heart disease (vasospastic form)
SE: constipation, Peripheral edema (ankles)
BAB
Decrease Heart rate and myocardium contractility
reduction, that ↓CO
2. Antagonistic effects on renal juxtaglomerular β1-adrenoceptors which ↓ renine secretion, but clinically significant vasodilation it does not cause. 1., 2. generation BAB can cause reflector vasoconstriction
3. Peripheral arterial vasodilation Is not direct BAB activity, But is an additional activity of several BAB with hybrid effect, i.e. 3rd generation BAB (e.g. nebivolol)
Metoprolol, propanolol, carvedilol, bisoprolol, nebivilol
SIRA
Centrally acting- don’t cause reflector tachycardia
Moxonidine
* imidazoline receptors are mainly concentrated in the ventrolateral part of the medulla oblongata
SIRA decreases SNS activity which decreases BP
AH + metabolic syndrome
(↑ tissue sensitivity to insulin)
Metildopa
Centrally acting antihypertensive agent—>alpha 2 autoreceptor agonist
Crosses BBB, decarboxilates to methyldopamine→
the active metabolite methylnorepinephrine →inhibits dopa-decarboxilaze.
As a false mediator, presynaptically accumulates in vesicles and stimulates presynaptic alpha 2 autoreceptors
Gestational hypertension
Emergency antihypertensives
Sodium nitroprusside and Labetolol
NO modulators
Sodium nitroprusside i/v
Short-acting
Direct action vasodilator, NO donor→ cGMP↑
↓ heart preload and afterload
Antihypertensive help in emergencies
Labetalol
Combined alpha and beta adrenoreceptor block
Antihypertensive help in emergencies and urgent situations